Pioneering Algorithmic Paradigms in Computational Drug Design - Khalili Hadad, Dr.Babak;Ghasemi, Reza
64,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
32 °P sammeln
  • Broschiertes Buch

About This Book:At the convergence of biology, computation, and design, this book invites the reader into a new epistemology of medicine where molecules are not only modeled but anticipated, and where algorithms do not merely analyze life, but begin to simulate its intelligence.Pioneering Algorithmic Paradigms in Computational Drug Design is a scholarly yet visionary treatise that explores how evolutionary computation, neural networks, and molecular dynamics are reshaping the architecture of drug discovery. From the structural depths of protein-ligand interactions to the abstract heights of…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
About This Book:At the convergence of biology, computation, and design, this book invites the reader into a new epistemology of medicine where molecules are not only modeled but anticipated, and where algorithms do not merely analyze life, but begin to simulate its intelligence.Pioneering Algorithmic Paradigms in Computational Drug Design is a scholarly yet visionary treatise that explores how evolutionary computation, neural networks, and molecular dynamics are reshaping the architecture of drug discovery. From the structural depths of protein-ligand interactions to the abstract heights of multi-objective optimization, it offers both precision and imagination.For Readers Seeking to Ask: Can code learn the logic of biology? What does it mean for an algorithm to design a molecule? Is it possible to preempt disease before biology declares it?Written not merely for those who work in science but for those who think with it this book serves as both a map and a mirror: charting the algorithmic future of pharmacology while reflecting the evolving role of the scientist in a world where life becomes legible to machines.
Autorenporträt
Dr. Babak Khalili Hadad is a professor of biochemistry and bioinformatics with 26+ years in academia and research. He leads innovations in drug design and AI-driven precision medicine, mentoring students and shaping global biomedical science.